跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

1366002

USP

利多卡因

United States Pharmacopeia (USP) Reference Standard

别名:

2-二乙氨基-N-（2,6-二甲苯基）乙酰胺, 利多卡因, 赛洛卡因

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C14H22N2O
CAS号:
137-58-6
分子量:
234.34
MDL號碼:
MFCD00026733
分類程式碼代碼:
41116107
PubChem物質ID:
329750054
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

lidocaine

製造商／商標名

USP

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

pharmaceutical (small molecule)

格式

neat

SMILES 字串

CCN(CC)CC(=O)Nc1c(C)cccc1C

InChI

1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)

InChI 密鑰

NNJVILVZKWQKPM-UHFFFAOYSA-N

基因資訊

human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

正在寻找类似产品? 访问 产品对比指南

相关类别

一般說明

本品按现行药典规定交付。所有为支持本产品而提供的信息，包括SDS和任何产品信息单均由药典颁发机构制定并发布。如需进一步信息和支持，请访问现行药典网站。

應用

利多卡因USP参考标准品用于指定质量测试和分析。

还可用于制备标准和系统适用性溶液，用于根据以下美国药典（USP）各论进行测定、鉴定和杂质分析：
  • 利多卡因
  • 盐酸利多卡因外用溶液
  • 盐酸利多卡因口服外用溶液
  • 盐酸利多卡因胶浆

生化／生理作用

Na+通道阻滞剂；在肠胃外给药后可迅速被吸收的IB类抗心律失常药。

分析報告

这些产品仅供测试和化验使用。它们不适用于人类或动物，也不能用于诊断、治疗或治愈任何类型的疾病。

其他說明

可能适用相应的销售限制。

相關產品

产品编号
说明
价格

L0595000

利多卡因, European Pharmacopoeia (EP) Reference Standard

L0600000

利多卡因, European Pharmacopoeia (EP) Reference Standard

PHR1257

利多卡因, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1669

利多卡因相关化合物A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1671

利多卡因相关化合物C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1673

利多卡因相关化合物H, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1670

利多卡因相关化合物B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1672

利多卡因相关化合物E, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1674

利多卡因相关化合物I, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1675

利多卡因相关化合物J, Pharmaceutical Secondary Standard; Certified Reference Material

1366080

N-(2,6-二甲基苯基)氯乙酰胺, United States Pharmacopeia (USP) Reference Standard

1366013

利多卡因 盐酸盐, United States Pharmacopeia (USP) Reference Standard

BP727

利多卡因, British Pharmacopoeia (BP) Reference Standard

BP214

利多卡因 盐酸盐, British Pharmacopoeia (BP) Reference Standard

PHR1995

利多卡因杂质G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1994

利多卡因杂质F, Pharmaceutical Secondary Standard; Certified Reference Material

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H302

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Lidocaine Hydrochloride Oral Topical Solution
United States Pharmacopeia, 44(4), 2626-2626 (2020)
Lidocaine Hydrochloride Jelly
United States Pharmacopeia, 43(6), 2625-2625 (2020)
Daniela Casoni et al.
Veterinary anaesthesia and analgesia, 42(3), 250-259 (2014-07-22)
To determine the potency ratio between S-ketamine and racemic ketamine as inductive agents for achieving tracheal intubation in dogs. Prospective, randomized, 'blinded', clinical trial conducted in two consecutive phases. 112 client-owned dogs (ASA I or II). All animals were premedicated
Bartholomeus C M Benno Haarman et al.
Brain, behavior, and immunity, 40, 219-225 (2014-04-08)
The "monocyte-T-cell theory of mood disorders" regards neuroinflammation, i.e. marked activation of microglia, as a driving force in bipolar disorder. Microglia activation can be visualized in vivo using [(11)C]-(R)-PK11195 PET. Indirect evidence suggests the hippocampus as a potential focus of
Song-Young Park et al.
American journal of physiology. Heart and circulatory physiology, 307(3), H346-H352 (2014-06-08)
Unlike cardiac and skeletal muscle, little is known about vascular smooth muscle mitochondrial respiration. Therefore, the present study examined mitochondrial respiratory rates in smooth muscle of healthy human feed arteries and compared with that of healthy cardiac and skeletal muscles.
查看所有相关文献

商品

LC/MS Analysis of Antiarrhythmic Drugs and Metabolites on Ascentis® Express HILIC

The benefit of HILIC over traditional reversed-phase chromatography is two-fold for both sample introduction and analyte detection. First, the high acetonitrile concentration of HILIC mobile phases allows for direct analysis of precipitated plasma samples without the need for additional sample solvent exchange. Second, the high acetonitrile content provides increased analyte response in positive ESI MS detection.

LC/MS Analysis of Antiarrhythmic Drugs and Metabolites on Ascentis® Express HILIC

Separation of Lidocaine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Amiodarone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material; (±)-Flecainide solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; N-Desethylamiodarone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material

相关内容

LC/MS (TOF) Analysis of Antiarrhythmic Drugs and Metabolites on Ascentis® Express HILIC

HILIC mobile phases consist of a high composition of acetonitrile, which facilitates the direct analysis of precipitated plasma samples without the need for additional sample solvent exchange.

LC/MS (TOF) Analysis of Antiarrhythmic Drugs and Metabolites on Ascentis® Express HILIC

Separation of Amiodarone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material; N-Desethylamiodarone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material; Lidocaine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; (±)-Flecainide solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门